VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GPAT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GPATGP-Act III Acquisition Corp.
$11.07$398M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGPATEarnings History

GPAT logoGP-Act III Acquisition Corp. (GPAT) Earnings History

Profitable

6 years of earnings data (2020–2025) · Positive TTM net income

TTM Net Income
$11M
● Profitable
TTM EPS (Diluted)
$0.39
Per share, diluted
YoY EPS Growth
-12.8%
Declining
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1Y-12.8%
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on Equity4.1%
Return on Assets3.9%
Record Annual Net Income$12MFY2025
Record Quarterly EPS$0.10Q3 2024
Consecutive Profitable Years2years
Q1 2026
Net Income$2M
EPS (Diluted)$0.06
YoY Growth-12.8%Declining
QoQ Growth-25.6%Declining

Loading earnings history...

GP-Act III Acquisition Corp. (GPAT) Earnings Overview

As of July 8, 2026, GP-Act III Acquisition Corp. (GPAT) reported trailing twelve-month net income of $11M, reflecting -12.8% year-over-year growth. The company earned $0.39 per diluted share over the past four quarters.

Looking at the long-term picture, GPAT's historical earnings data spans multiple years. The company achieved its highest annual net income of $12M in fiscal 2025, representing a new all-time high.

GP-Act III Acquisition Corp. maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →

Compared to peers including PSFE (-$199M net income, -10.7% margin), ACIC ($105M net income, 31.8% margin), GS ($18.07B net income, 13.7% margin), GPAT has comparable earnings metrics. Compare GPAT vs PSFE →

GPAT Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
GPAT logoGPATCurrent
$11M$0.39-4.1%-12.8%—
PSFE logoPSFE
-$199M$-3.90-10.7%-23.8%-972.2%
ACIC logoACIC
$105M$2.1031.8%38.6%+40.5%
GS logoGS
$18.1B$58.6613.7%13.9%+26.6%
MS logoMS
$18.2B$11.4114.7%15.5%+28.3%
JPM logoJPM
$58.9B$21.0820.4%16.1%+1.5%
Best in group
Lowest in group

GPAT Historical Earnings Data (2020–2025)

5 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$12M+37.1%$-551,918$0.41--
2024$9M+61862.0%$-565,000$0.47--
2023$-14,041+54.5%$-14,041$-0.00--
2022$-30,844-676.3%$-30,840$-0.00--
2020$-3,973-$-3,970$-0.00--

Download Data

Export GPAT earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

6+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GPAT — Frequently Asked Questions

Quick answers to the most common questions about buying GPAT stock.

What is GPAT earnings per share (EPS)?

GPAT trailing twelve-month (TTM) diluted EPS is $0.39, reflecting -12.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2025 is available in the table on this page.

What is GP-Act III Acquisition Corp.'s net income?

GP-Act III Acquisition Corp. (GPAT) trailing twelve-month net income is $11M as of 2025. Earnings declined -12.8% year-over-year. GP-Act III Acquisition Corp. has been profitable for 2 consecutive years.

Is GPAT profitable?

Yes, GPAT is profitable with a TTM net income of $11M and a net profit margin of N/A. GP-Act III Acquisition Corp. has generated profits for 2 consecutive years.

What is GPAT's earnings growth rate?

GPAT compound annual EPS growth rates (CAGR): 1-Year: -12.8%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2025.

What are GPAT's profit margins?

GP-Act III Acquisition Corp. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is +4.1%.

Is GPAT growing earnings?

GPAT earnings are declining — EPS fell -12.8% year-over-year. TTM net income dropped to $11M. This contrasts with the 5-year CAGR of N/A.

What was GPAT's best earnings year?

GP-Act III Acquisition Corp.'s highest annual net income on record is $12M, achieved in fiscal year 2025. Earnings history on this page spans 2020 to 2025 and includes all annual and quarterly figures.

What were GPAT's earnings last quarter?

GPAT's most recent reported quarter was Q1 2026. Net income was $2M with diluted EPS of $0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.

GPAT Earnings Over Time (2020–2025)

Net income & EPS — annual and quarterly view